Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development

Recent evidence suggested that the mRNA vaccine has been effective for many tumors, but its progress in gliomas was slow. In this study, we screened potential tumor antigens and suitable populations for mRNA vaccine to develop mRNA vaccine for glioma. We integrated the normalized RNA sequencing expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhuohui, Wang, Xiang, Yan, Zhouyi, Zhang, Mengqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249984/
https://www.ncbi.nlm.nih.gov/pubmed/35285582
http://dx.doi.org/10.1002/cam4.4633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249984/
https://www.ncbi.nlm.nih.gov/pubmed/35285582
http://dx.doi.org/10.1002/cam4.4633

Ejemplares similares